These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31015226)

  • 1. Statins for primary prevention of cardiovascular disease: modelling guidelines and patient preferences based on an Irish cohort.
    Byrne P; Cullinan J; Gillespie P; Perera R; Smith SM
    Br J Gen Pract; 2019 Jun; 69(683):e373-e380. PubMed ID: 31015226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
    JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA).
    Murphy C; Bennett K; Fahey T; Shelley E; Graham I; Kenny RA
    BMJ Open; 2015 Jul; 5(7):e008017. PubMed ID: 26169806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.
    McElduff P; Jaefarnezhad M; Durrington PN
    Heart; 2006 Sep; 92(9):1213-8. PubMed ID: 16717068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.
    Byrne P; Cullinan J; Murphy C; Smith SM
    BMJ Open; 2018 Feb; 8(2):e018524. PubMed ID: 29439070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.
    Thanassoulis G; Williams K; Altobelli KK; Pencina MJ; Cannon CP; Sniderman AD
    Circulation; 2016 Apr; 133(16):1574-81. PubMed ID: 26945047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug costs associated with non-adherence to cholesterol management guidelines for primary prevention of cardiovascular disease in an elderly population: the Rotterdam study.
    Gumbs PD; Verschuren WM; Mantel-Teeuwisse AK; de Wit AG; Hofman A; Trienekens PH; Stricker BH; de Boer A; Klungel OH
    Drugs Aging; 2006; 23(9):733-41. PubMed ID: 17020397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.
    Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD
    BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of three widely used lipid management guidelines in the EPIC-Norfolk cohort.
    Colkesen EB; Jørstad HT; Peters RJ; Boekholdt SM; Tijssen JG; Ferket BS; Wareham NJ; Khaw KT
    Eur J Prev Cardiol; 2013 Feb; 20(1):98-106. PubMed ID: 22345678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.
    Pavlović J; Greenland P; Deckers JW; Kavousi M; Hofman A; Ikram MA; Franco OH; Leening MJ
    Eur J Prev Cardiol; 2018 Mar; 25(4):420-431. PubMed ID: 29171772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
    Hamoui O; Omar MI; Raal FJ; Rashed W; Kane A; Alami M; Abreu P; Mashhoud W; Alsheikh-Ali AA
    BMC Cardiovasc Disord; 2019 Mar; 19(1):61. PubMed ID: 30876390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary Prevention.
    Thanassoulis G; Sniderman AD; Pencina MJ
    JAMA Cardiol; 2018 Nov; 3(11):1090-1095. PubMed ID: 30422172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin initiations and QRISK2 scoring in UK general practice: a THIN database study.
    Finnikin S; Ryan R; Marshall T
    Br J Gen Pract; 2017 Dec; 67(665):e881-e887. PubMed ID: 29061715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are recent statin recommendations to employ fixed doses and abandon targets effective for treatment of hypercholesterolaemia? Investigation based on number needed to treat.
    Soran H; Adam S; Durrington PN
    Eur J Prev Cardiol; 2017 Jan; 24(1):76-83. PubMed ID: 27609614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts.
    Yebyo HG; Aschmann HE; Yu T; Puhan MA
    BMC Cardiovasc Disord; 2018 May; 18(1):97. PubMed ID: 29776337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Statins for Primary Prevention: Selection of Risk Threshold and Implications Across Race and Gender.
    Goyal A; Cooper HA; Aronow WS; Nagpal P; Yandrapalli S; Nabors CC; Frishman WH
    Am J Med; 2018 Oct; 131(10):1234-1237. PubMed ID: 29928863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.